The immunological effects of three doses of a live attenuated hepatitis a vaccine (H2 strain) in 8 years
Liu, H.-F.; Zhang, X.-J.; Zhang, J.-L.; Hao, Z.-Y.; Zhang, Z.-Y.; Ma, J.-C.; Chen, J.-C.; Chu, J.; Wang, X.-Y.; Xu, Z.-Y.
Zhonghua Shi Yan he Lin Chuang Bing du Xue Za Zhi 23(3): 180-181
2009
ISSN/ISBN: 1003-9279 PMID: 20104771 Document Number: 633755
To observe the immunological effects of three doses of H2 strain live attenuated hepatitis A vaccine 8 years after the administration and to compare with that of one dose of the vaccine. In a country area, 110 children of 1 to 7 years old susceptible to HAV were screened and administered with one dose of the vaccine, as group B; Group A were 42 children from one of the villages and administered with 3 doses of the vaccine according to 0, 2, 6 month schedule. Blood samples were taken for the children 1, 2, 6, 7, 8, 12, 24, 36 and 96 months after the administrations respectively and detected for anti-HAV antibody. For group B, the sero conversion rate of anti-HAV and GMC reached peak at 92.2% and 126.2 mIU/ml respectively, and then, began to drop with time; For group A, after 2 dose of the vaccine, the sero-conversion rate reached 100%, and the GMC reached peak of 2 739 mIU/ml one month after the third dose at 7 months. So that, group A has a better short-term immunological effects than that of group B. During 36 through 96 months, the anti-HAV positive rate in group B was 75%-71% and 80-89 mIU/ml respectively, and comparatively in group A were 100% and 918.2-480.6 mIU/ml respectively. The differences between group A and B were significantly important. A 3-dose schedule administration of H2 strain live attenuated hepatitis A vaccine has better immunological effects than 1-dose schedule in 8years and further observations are needed.